Wat betsjut "Dúdlik"?
It bist draacht de mutaasje net. It sil de sykte net ûntwikkelje en sil it net trochjaan.
The DNA test for Progressive Retinal Atrophy in Giant Schnauzers (PRA-NECAP1) is essential for responsible breeding and early diagnosis. PRA-NECAP1 is a hereditary eye disorder causing gradual vision loss and eventual blindness in affected dogs. By identifying carriers and affected individuals through genetic testing, breeders can make informed decisions to reduce the incidence of this debilitating condition. Early detection via the PRA-NECAP1 DNA test helps improve the quality of life for Giant Schnauzers by enabling timely care and management. This test is a vital tool for preserving the health and vision of future generations. Ensure your Giant Schnauzer’s genetic health with the PRA-NECAP1 DNA test today. Protect your dog’s eyesight and support responsible breeding practices.
The DNA test for Progressive Retinal Atrophy (PRA-NECAP1) in Giant Schnauzers identifies a genetic mutation responsible for this inherited eye disease. PRA causes gradual vision loss, eventually leading to blindness. Early detection through genetic testing helps breeders make informed decisions to reduce the incidence of PRA in future generations. This test is a valuable tool for maintaining the health and quality of the Giant Schnauzer breed. Regular screening supports responsible breeding and the well-being of affected dogs.
Dizze DNA-test is opnommen fanôf ús pakket Basic - en is ek diel fan 'e pakketten Basic, Standard, Advanced, Complete.
Besjoch DNA-testpakketten →Progressive Retinal Atrophy (PRA) is a hereditary eye disorder that leads to the degeneration of the retina, ultimately resulting in vision loss. In Giant Schnauzers, the specific form of PRA is associated with mutations in the NECAP1 gene. This condition typically manifests as night blindness in the early stages, gradually progressing to complete vision impairment.
Signs of PRA-NECAP1 may not be immediately evident, as affected dogs often adapt to their diminishing vision. Common symptoms include difficulty seeing in low light conditions, an increased reliance on smell, and a noticeable change in behavior, such as hesitance in unfamiliar environments. As the disease progresses, affected dogs may exhibit signs of confusion or anxiety, particularly in new or dimly lit settings.
The PRA-NECAP1 form is caused by a mutation in the NECAP1 gene, which plays a critical role in the normal functioning of photoreceptor cells in the retina. This gene is essential for maintaining the health of these cells, and when defective, it leads to their premature death. Understanding the genetic basis of this condition is crucial for breeders and pet owners, as it allows for informed breeding practices aimed at reducing the prevalence of this hereditary disease.
DNA testing for PRA-NECAP1 is an essential tool for breeders and dog owners. By identifying carriers of the mutation, breeders can make informed decisions about mating practices to minimize the risk of producing affected puppies. This proactive approach is vital for maintaining the health of the breed and reducing the incidence of PRA in Giant Schnauzers.
While there is currently no cure for PRA-NECAP1, managing the condition involves providing a supportive environment for affected dogs. Owners should ensure their homes are safe and familiar to minimize the risk of accidents due to vision loss. Regular veterinary check-ups can help monitor the progression of the disease and address any emerging health issues. Additionally, providing mental stimulation and maintaining social interactions can enhance the quality of life for dogs with this condition.
Progressive Retinal Atrophy in Giant Schnauzers, particularly the PRA-NECAP1 variant, is a significant concern for breeders and dog owners. Through genetic testing and responsible breeding practices, the impact of this hereditary condition can be mitigated, ensuring healthier future generations. Understanding the symptoms, management strategies, and genetic aspects of PRA-NECAP1 is essential for supporting affected dogs and enhancing their quality of life.
It bist draacht de mutaasje net. It sil de sykte net ûntwikkelje en sil it net trochjaan.
Nee, it bist is oer it algemien sûn, mar kin de mutaasje oerjaan oan har neiteam.
It draacht twa mutearre eksimplaren. Klinyske tekens wurde ferwachte ôfhinklik fan de sykte. It moat net fokt wurde.
Guon sykten binne seks-keppele, sadat harren útdrukking fariearret ôfhinklik fan de bist syn seks.
This DNA test detects the mutation associated with Progressive Retinal Atrophy In Giant Schnauzer (PRA-NECAP1) in order to identify clear, carrier, or at-risk animals.
DNA-testen helpt fokkers om feiliger parings te plannen en it risiko te ferminderjen fan it oerdragen fan de mutaasje nei neiteam.
De erflike modus rapportearre foar dizze test is Autosomal Recessive.
This test analyses the mutation NECAP1 c.544G>A.
Net needsaaklik. Ynterpretaasje hinget ôf fan it erflik patroan en de resultearjende genotyp.
Hitti Rebekkah J, Oliver James A C, Schofield Ellen C, Bauer Anina, Kaukonen Maria, Forman Oliver P, Leeb Tosso, Lohi Hannes, Burmeister Louise M, Sargan David, Mellersh Cathryn S. Whole Genome Sequencing of Giant Schnauzer Dogs with Progressive Retinal Atrophy Establishes NECAP1 as a Novel Candidate Gene for Retinal Degeneration. Genes (Basel). 2019 May 21;10(5):385. doi: 10.3390/genes10050385.
Jo privacy, jo kar
Wy brûke essensjele cookies om de webside út te fieren. Opsjonele cookies (lykas oanbieders fan ynbêde ynhâld) binne standert útskeakele en binne allinich ynskeakele as jo it iens binne. Jo kinne jo kar op elk momint feroarje mei de knop "Koekjes".
Fereaske foar kearnfunksjes en feiligens. Altyd ynskeakele.
Ferbetteret funksjes lykas foarkarbesparring of net-reklame-ynbêden.
Helpt ús sitegebrûk te begripen. Standert útskeakele.
Advertearje / folgjen oer siden (guon fideo / kaarten ynbêde). Standert útskeakele.